SomaLogic is proteomics company, founded in 2000, with the goal of improving the well-being and quality of life of every individual by transforming how diseases were detected, diagnosed and managed

SomaLogic scientists developed a ground-breaking proteomics technology that overcomes the significant challenges of existing protein measuring technologies, with multiple applications across the biological and medical sciences. The company's mission is to leverage proprietary technology to create, develop and commercialize innovative life science research tools and breakthrough clinical products that transform healthcare.

The SomaScan platform allows scientists and researchers to identify protein biomarkers for diseases and conditions, and apply them to drug and diagnostic research and development.